This job has expired


Spark Therapeutics
Philadelphia, Pennsylvania
Salary not provided
Closing date
Apr 2, 2022

View more

Health Sciences, Drug Development
Job Type
Staff Scientist
Organization Type
You need to sign in or create an account to save a job.

Job Details

Primary Duties

The Research Scientist will be a member of the Immunogenicity prediction Team within the Immunology

Department. The successful candidate’s primary responsibility will be to execute and improve

established protocols in immunology. She/He will coordinate with the lead and scientists to perform in vitro and ex vivo assays with the goal of advancing knowledge and understanding the cause and effect of gene therapy products interaction with the immune system.

The Research Scientist will be responsible for:

  • Evaluating the immunogenicity risk assessment of the candidate therapeutic vectors in preclinical development across different functional areas
  • Develops and implement novel and innovative in-vitro and ex-vivo immune assays or optimize existing cell-based assays to support preclinical and clinical studies based on regulatory guidelines.
  • Validate existing cutting-edge techniques (Single-cell analysis, RNASeq, Proteomics, flow cytometry, MSD, ELISPOT etc.) for the purpose of AAV vectors immunogenicity prediction.
  • Strategic planning, execution, and reporting of pre-clinical immunology studies; proposes novel AAV immunogenicity strategies to modulate immune responses to gene therapy.
  • Directs external collaborations with the support of a dedicated business development partner, as needed
  • Write and revise SOPs to reflect best practices and process improvement. Perform complex data analyses and prepare reports and scientific presentations.
  • Keep abreast of new scientific and technical advances reported in the literature to support expansion and improvement of immunoassay portfolio.
  • Communicate with internal and external entities, including vendors, Clinical Operations, CROs and collaborators, to ensure obligations are met with regards to custom reagent preparation, sample receipt, sample processing, and data provision

Design, planning, execution, and reporting of immunogenicity assays

Data analysis, data review and preparation of study and sample results and reports

Assay development and optimization/troubleshooting

Write and revise SOPs, sample management

Coordinate and communicate with vendors, CROs and collaborators

Education and Experience Requirements

  • Ph.D. in Immunology or related field required
  • 3+ years of post-graduate experience, preferably in gene therapy
  • Experience in MSD, flowcytometry, Elispot/Fluorospot, primary cell culture, qPCR, AAV etc
  • Experience in research, CRO and/or industry environment.
  • Extensive experience using analytical tools such as bioinformatics tools, GloMax, Prism and Flowjo.

Key Skills, Abilities, and Competencies

  • A strong background in immunology and AAV gene therapy is preferred
  • Expertise in development and execution of immunoassays and cell culture using primary cells or cell lines, new innovative genomics, and proteomic assays
  • Ability to work independently and as part of a team, self-motivation, adaptability, and a positive attitude
  • Excellent organizational, communication and collaborations skills
  • Keep accurate records, follow instructions, and comply with company policies

Complexity and Problem Solving

  • Develop solutions to a variety of problems of moderate scope and complexity. Refers to policies and practices for guidance.
  • Works on problems of moderate scope where analysis of situations or data requires a review of a variety of factors. Exercises judgment within defined procedures and practices to determine appropriate action.

Please be aware that Spark mandates COVID-19 vaccination of all employees regardless of work location. Accommodations may be made in accordance with applicable law.

Nearest Major Market: Philadelphia

Join the Spark Team

We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our shared mission is to challenge the inevitability of genetic disease by discovering, developing, and delivering treatments in ways unimaginable - until now.

We don't follow footsteps. We create the path.


At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases.

Founded in March 2013 as a result of the technology and know-how accumulated over two decades at Children’s Hospital of Philadelphia (CHOP), our investigational therapies have the potential to provide long-lasting effects, dramatically and positively changing the lives of patients with conditions where no, or only palliative, therapies exist. Greater understanding of the human genome and genetic abnormalities have allowed our scientists to tailor investigational therapies to patients suffering from very specific genetic diseases. This approach holds great promise in developing effective treatments to a host of inherited diseases. Our initial focus is on treating orphan diseases.

Headquartered in dynamic Philadelphia, we are a diverse, experienced team united in our goal to break down barriers for people and families affected by genetic diseases. As our name suggests, our investigational, one-time therapies are designed to spark healthy biology, and deliver potentially life-altering transformation for people and families affected by genetic disease. Spark is a member of the Roche Group.

Find Us
3737 Market Street
Suite 1300
United States
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert